Can weight-loss drugs make you blind?

Also: No action on interest rates ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌  ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ 

eNewspaper   |    Crosswords   |    Horoscopes The Daily Money ALL THE MONEY NEWS YOU NEED TO KNOW Thu Jan 29 2026 Daniel de Visé |  Personal Finance Reporter Good morning! It's Daniel de Visé with your Daily Money. A Maryland truck driver suffered an "eye stroke" that left him blind, first in one eye and then the other, Chris Kenning and Austin Fast report. He filed a lawsuit that blames the popular class of weight-loss drugs known as GLP-1 receptor agonists, which include Ozempic, Wegovy and Mounjaro. Are they responsible for his condition? No change in interest rates at January meet The Federal Reserve opted to leave interest rates unchanged at the central bank's January meeting. Can we expect rate cuts later in 2026? 📰 More stories you shouldn't miss 📰 • Would a government shutdown impact tax returns? • How to buy gold safely in 2026 • Costco sued over rotisserie chicken • A primer on energy-efficient windows • These SUVs thrive in winter weather 📰 A great read 📰 And here's a popular story from 2025 that you may have missed. Read it! Share it! Many Americans consider $1.5 million to be a retirement "magic number": If you've saved that much, the theory goes, you should be good. Here's how long that sum lasts in every state. Daniel de Visé covers personal finance for USA TODAY. The Daily Money breaks down complex consumer and financial news. Subscribe here. 'My colon blew up.' Weight-loss drug lawsuits allege serious harm. More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight. READ MORE Fed pauses rate cuts to start 2026. What's next? The January meeting marks the first since Fed Chair Jerome Powell confirmed the Department of Justice subpoenaed the central bank. READ MORE Got $1.5m? Here's how many retirement years it buys in every state. Some states are surprisingly affordable for retirees with seven-figure savings. Others, not so much. READ MORE Would a government shutdown impact tax returns? What to know. The IRS's ability to stay open during a shutdown depends on funding. How will filings and refunds be impacted? READ MORE 2026 gold buying guide and safety checklist Gold prices are at record highs. Learn what's driving the surge, whether to buy coins, bars or a Gold IRA and how to buy gold safely in 2026. READ MORE Costco sued over its $4.99 rotisserie chicken. Here's why. The plaintiffs and their lawyers allege that Costco "has systemically cheated customers out of tens—if not hundreds—of millions of dollars." READ MORE Are energy-efficient windows worth it? Energy-efficient windows can improve comfort and reduce heat loss. Learn how they work, what features matter and when replacement makes sense. READ MORE 3 family SUVs that shine in winter weather Winter often comes with snow and ice. These SUVs are designed to help drivers overcome frozen obstacles safely. READ MORE Barbie launches first autistic doll. Here's what it looks like. The new autistic Barbie aims to represent how individuals with autism experience the world around them, Mattel said. READ MORE Download USA TODAY's app to get to the heart of news Our app gives you award-winning coverage, crosswords, audio storytelling, eNewspaper and more. READ MORE Sign up for the news you want Exclusive newsletters are part of your subscription, don't miss out! We're always working to add benefits for subscribers like you. SEE ALL NEWSLETTERS ➔ Newsletters   |    eNewspaper   |    Crosswords Follow Us Unsubscribe  •   Manage Newsletters  •   Terms of Service  •   Privacy Policy/Your California Privacy Rights  •  Privacy Notice  •   Do Not Sell My Info/Cookie Policy  •   Feedback